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Background
The aim of study was to study the prognostic factors
after surgery with curative intend for pulmonary carci-
noid tumors - typical carcinoid (TCs) and atypical carci-
noid (AtCs).
Methods
Surgically resected specimen (men n = 59; women n = 72,
age 48 ± 15) from 111 TC (84.7%) and 20 AtC (15.3%)
patients were studied. The histological type, T-status,
N-status (TC - 94 N0, 17 N1/2; AtC - 16 N0, 4 N1),
pTNM stage (TC-I n = 81, II n = 17, III+IV = 13; AtC-I
n = 12, II-IV n = 8), surgery (55 simple lobectomies,
16 bilobectomies, 24 pneumonectomies (4 extended),
15 segmentectomies, 16 sleeve lobectomy (in 2 of them
combined with sleeve resection of pulmonary artery),
5 sleeve resection of main bronchus), and immunohisto-
chemical expression (on 64 TCs and 13 AtCs) of p-HspB5,
Hsp27 and mTOR were evaluated. Kaplan-Meier,
Wilcoxon, Cox regression analyses were the statistical
methods used.
Results
The overall 5-, 10- and 15-year survival for TCs were
84%, 70% and 62% respectively; and for AtCs–53% and
0%. The difference in mean survival time between TCs
(14 years) and AtCs (7 years) was significant (p = 0.004).
The median survival time was significantly longer in N0
status (N0-213 months, N1/2-54, p = 0.002), in I and II
pTNM status (I/II-213 months, III/IV-27, p = 0.020) and
in cases positive for mTOR (p = 0.035). T status,
p-HspB5, Hsp27 expression were not statistically signifi-
cant factors for survival (p > 0.05).The Cox analysis
confirmed the prognostic significance of histology type
(HR 3.32; p = 0.007), N status (HR 3.51; p = 0.014) and
pTNM stage (HR 11.27; p < 0.001).
Conclusion
Postoperative survival is significantly related to the histol-
ogy type, N status, pTNM stage and mTOR expression.
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